Cargando…
A Novel Epigenetic Machine Learning Model to Define Risk of Progression for Hepatocellular Carcinoma Patients
Although extensive advancements have been made in treatment against hepatocellular carcinoma (HCC), the prognosis of HCC patients remains unsatisfied. It is now clearly established that extensive epigenetic changes act as a driver in human tumors. This study exploits HCC epigenetic deregulation to d...
Autores principales: | Bedon, Luca, Dal Bo, Michele, Mossenta, Monica, Busato, Davide, Toffoli, Giuseppe, Polano, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865606/ https://www.ncbi.nlm.nih.gov/pubmed/33499054 http://dx.doi.org/10.3390/ijms22031075 |
Ejemplares similares
-
Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies
por: Mossenta, Monica, et al.
Publicado: (2020) -
Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies
por: Mossenta, Monica, et al.
Publicado: (2022) -
New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma
por: Mossenta, Monica, et al.
Publicado: (2019) -
The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma
por: Busato, Davide, et al.
Publicado: (2022) -
A New Epigenetic Model to Stratify Glioma Patients According to Their Immunosuppressive State
por: Polano, Maurizio, et al.
Publicado: (2021)